Lifevantage Corp financial data

Symbol
LFVN on Nasdaq
Industry
Pharmaceutical Preparations
Location
3300 Triumph Blvd, Suite 700, Lehi, UT
Fiscal year end
June 30
Former names
LIFELINE THERAPEUTICS, INC. (to 12/6/2006), YAAK RIVER RESOURCES INC (to 9/28/2004)
Latest financial report
10-K - Q2 2024 - Aug 28, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 169 % -16.5%
Quick Ratio 65.8 % -22.1%
Debt-to-equity 129 % +24.8%
Return On Equity 10.7 % +39.5%
Return On Assets 4.68 % +23.8%
Operating Margin 2.16 % +8.52%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 12.5M shares -1.75%
Common Stock, Shares, Outstanding 12.5M shares -0.89%
Entity Public Float 68.1M USD +54.1%
Common Stock, Value, Issued 1K USD 0%
Weighted Average Number of Shares Outstanding, Basic 12.5M shares -0.79%
Weighted Average Number of Shares Outstanding, Diluted 13M shares +3.33%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 200M USD -6.2%
Research and Development Expense 700K USD +16.7%
Operating Income (Loss) 4.33M USD +1.71%
Nonoperating Income (Expense) 18K USD -340%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 4.35M USD +8.78%
Income Tax Expense (Benefit) 1.41M USD -3.15%
Net Income (Loss) Attributable to Parent 2.94M USD +15.6%
Earnings Per Share, Basic 0.24 USD/shares +20%
Earnings Per Share, Diluted 0.23 USD/shares +15%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 16.9M USD -21.8%
Accounts Receivable, after Allowance for Credit Loss, Current 2.95M USD +82.9%
Inventory, Net 15.1M USD -6.33%
Assets, Current 37.6M USD -15%
Deferred Income Tax Assets, Net 4.27M USD +42.7%
Property, Plant and Equipment, Net 7.81M USD -14%
Operating Lease, Right-of-Use Asset 9.57M USD +9.51%
Intangible Assets, Net (Excluding Goodwill) 323K USD -29%
Other Assets, Noncurrent 680K USD +19.5%
Assets 60.3M USD -8.81%
Accounts Payable, Current 5.85M USD +67%
Accrued Liabilities, Current 7.87M USD -0.73%
Contract with Customer, Liability, Current 860K USD +3.12%
Liabilities, Current 22.3M USD +13.8%
Operating Lease, Liability, Noncurrent 11.8M USD +2.03%
Other Liabilities, Noncurrent 198K USD -33.8%
Liabilities 34.3M USD +9%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.92M USD -40.8%
Retained Earnings (Accumulated Deficit) -109M USD -10.6%
Stockholders' Equity Attributable to Parent 26M USD -25%
Liabilities and Equity 60.3M USD -8.81%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 4.77M USD
Net Cash Provided by (Used in) Financing Activities -6.67M USD -1933%
Net Cash Provided by (Used in) Investing Activities -1.13M USD -55.8%
Common Stock, Shares Authorized 40M shares 0%
Common Stock, Shares, Issued 12.5M shares -0.89%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.2M USD -24.5%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 16.9M USD -21.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 720K USD +2.27%
Deferred Tax Assets, Gross 8.55M USD +8.81%
Operating Lease, Liability 13.6M USD +4.01%
Payments to Acquire Property, Plant, and Equipment 1.13M USD +55.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 1.13M USD +9.07%
Lessee, Operating Lease, Liability, to be Paid 14.8M USD -0.88%
Operating Lease, Liability, Current 1.81M USD +19.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.15M USD +34.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.11M USD +10.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.03 pure 0%
Deferred Income Tax Expense (Benefit) -1.7M USD +2.96%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.24M USD -34.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.15M USD +30.7%
Deferred Tax Assets, Operating Loss Carryforwards 271K USD +8.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.04M USD +20.7%
Operating Lease, Payments 2.19M USD -26.4%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 918K USD +9.16%
Interest Expense 7K USD -50%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%